Diadema Partners »

Septerna shares owned by Diadema Partners

Quarter-by-quarter ownership of Septerna (SEPN) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Septerna

Tip: Access up to 7 years of quarterly data

All positions including Septerna held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Septerna by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.9k 202 24.03

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Septerna

RA Capital Management
TRV GP V
Driehaus Capital Management
Trv Gp Vi
Samsara BioCapital
Goldman Sachs Group
Siren
BlackRock
BVF
venBio Select Advisor
Vanguard Capital Management
ADAR1 Capital Management
PRIMECAP Management Company
Henderson Group
First Light Asset Management

View all funds holding Septerna